Dublin, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The "Medical Imaging Reagents Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
The global medical imaging reagents market is expected to grow from $13.04 billion in 2022 to $14.06 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The medical imaging reagents market is expected to reach $18.24 billion in 2027 at a CAGR of 6.7%.
Medical imaging reagents refer to the substances that are used by medical practitioners and researchers to enhance the visibility of the structures and organs to identify new development and diagnose or treat disease. It is used to visualise structures or organs, allowing clinicians to better diagnose and identify diseases. 
The main classes of medical imaging reagents are contrast reagents, optical reagents, and nuclear reagents. Contrast agents refer to substances that enhance the radiodensity and increase the contrast of structures or fluids in medical imaging by altering the way that electromagnetic radiation or ultrasound waves pass through the body.
The various types of technology involves are nanoparticles, fluorescent dyes, radiopharmaceuticals, fluorescent proteins, and quantum dots, that involve various modes such as X-ray, CT scan, ultrasound, and MRI scan. These are used for several applications, such as neurological disorder, cardiovascular disorder, cancer, gastrointestinal disorder, musculoskeletal disorder, nephrological disorder, and others, and are used by various end-users, including biotechnology companies, pharmaceutical companies, and diagnostic labs.
The increase in the prevalence of chronic diseases is expected to propel the growth of the medical imaging reagents market going forward. Chronic diseases refer to conditions that last one year or longer and require continuous medical attention, which may worsen over time. Chronic diseases require medical imaging reagents to diagnose and detect diseases by visualizing organs and affected structures.
For instance, in 2022, according to the American Cancer Society, a US-based voluntary organization, the number of new cancer cases and fatalities expected was estimated to be 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States.
Furthermore, in December 2021, according to the IDF Diabetes Atlas Tenth Edition 2021 report published by the International Diabetes Federation, a Belgium-based umbrella organization of national diabetes associations, 537 million persons (20-79 years old) were estimated to have diabetes in 2021. By 2030, there will be 643 million diabetics worldwide, and by 2045, there will be 783 million. The increase in the prevalence of chronic diseases is driving the growth of the medical imaging reagents market.
Product innovations are a key trend gaining popularity in the medical imaging reagents market. Major companies operating in the medical imaging reagents market are focused on developing new solutions to sustain their position in the market. For instance, in March 2020, Sony Corporation, a Japan-based conglomerate corporation, launched KIRAVIA DyesT, an innovative new fluorescent dyes for use in reagents for a wide range of life science applications.
They additionally aid in imaging programs such as microscopy. This polymer structure is intended to boost brightness by minimizing the quenching impact between adjacent dyes on the backbone. More colors are added to the backbone to make brighter polymers. It enables higher brightness reagents for the life science segment, such as immunology and regenerative medicine, and is utilized in the life sciences sectors to explore the qualities of tissues and cells.
In September 2021, PerkinElmer Inc., a US-based provider of detection and imaging technologies, acquired Bio Legend for $5.25 billion. Through this acquisition, PerkinElmer expands its life science franchise into cytometry, proteogenomic, multiplex assays, recombinant proteins, magnetic cell separation, and bioprocessing. Bio Legend is a US-based developer of reagents supporting microscopy-based imaging of cells and tissue samples.
North America was the largest region in the medical imaging reagents market in 2022. The countries covered in the medical imaging reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 275 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value (USD) in 2023 | $14.06 billion |
| Forecasted Market Value (USD) by 2027 | $18.24 billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
Major players in the medical imaging reagents market are
- General Electric Company (GE Healthcare)
- Lantheus Holdings Inc.
- Thermo Fisher Scientific Inc.
- Bayer AG
- Bracco SpA
- Siemens AG
- PerkinElmer Inc.
- Cardinal Health Inc.
- Shimadzu Corporation
- Philips Healthcare
- SA Laboratoires Andre Guerbet
- Li-cor Biosciences Inc.
- Canon Medical Systems Corporation
- Fujifilm Healthcare
- Aidoc Medical
Key Topics Covered:
1. Executive Summary
2. Medical Imaging Reagents Market Characteristics
3. Medical Imaging Reagents Market Trends And Strategies
4. Medical Imaging Reagents Market - Macro Economic Scenario
4.1. COVID-19 Impact On Medical Imaging Reagents Market
4.2. Ukraine-Russia War Impact On Medical Imaging Reagents Market
4.3. Impact Of High Inflation On Medical Imaging Reagents Market
5. Medical Imaging Reagents Market Size And Growth
5.1. Global Medical Imaging Reagents Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Medical Imaging Reagents Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Medical Imaging Reagents Market Segmentation
6.1. Global Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Contrast Reagents
- Optical Reagents
- Nuclear Reagents
6.2. Global Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Nanoparticles
- Fluorescent Dyes
- Probes Radiopharmaceuticals
- Fluorescent Proteins
- Quantum Dots
6.3. Global Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- X-ray
- CT Scan
- Ultrasound
- MRI Scan
6.4. Global Medical Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Neurological Disorder
- Cardiovascular Disorder
- Cancer
- Gastrointestinal Disorder
- Musculoskeletal Disorder
- Nephrological Disorder
- Other Applications
6.5. Global Medical Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Biotechnology Companies
- Pharmaceutical Companies
- Diagnostic Labs
7. Medical Imaging Reagents Market Regional And Country Analysis
7.1. Global Medical Imaging Reagents Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Medical Imaging Reagents Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/1y10tb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
